8158 — China Regenerative Medicine International Share News
0.000.00%
- HK$66.94m
- HK$103.36m
- HK$72.06m
Brief: China Regenerative Medicine International Announces Disposal Of Two Indirect Units
Brief: China Regenerative Medicine International Posts Qtrly Loss Attributable Of HK$148.7 Mln
Brief: China Regenerative Medicine International Says Wang Xuejun Resigned As CEO
Brief: China Regenerative Medicine International Appoints Qiu Bin As Exec Director
Brief: China Regenerative Medicine International Posts Loss For Year Attributable Hk$404.6 Million
Brief: China Regenerative Medicine Int'l Enters Into Placing Agreement With SBI And Grand Partners
Brief: China Regenerative Medicine International Announces Further Sales Of Interest By Unit
Brief: China Regenerative Medicine International Announces Termination Of Open Offer
Brief: China Regenerative Medicine International Says Considering To Dispose 85% Stake In A Fund
Brief: China Regenerative Medicine International Says Unit To Dispose 15% Of Investment In Fund
Brief: China Regenerative Medicine International Announces Lapse Of Cooperation Agreement
Brief: China Regenerative Medicine International Proposes To Raise Between About Hk$351.72 Mln & Hk$354.23 Mln
Brief: China Regenerative Medicine International Responds to Unusual Price And Trading Volume Movements
Brief: China Regenerative Medicine International Posts Qtrly Loss Attributable HK$22.2 Mln
Brief: China Regenerative Medicine International Appoints Wang Chuang As Chairman
Brief: China Regenerative Medicine International & Chung Lee Securities Agree To Terminate Placing Agreement
Brief: China Regenerative Medicine International Says Qtrly Loss Attributable HK$36.7 Mln
Brief: China Regenerative Medicine International To Place Up To 3.52 Bln Shares
Brief: China Regenerative Medicine International Says Trading In Shares Of Co Will Be Suspended From 1 April